Tetra Bio-Pharma to Present Key Research Findings as Part of Food and Drug Administration (FDA) Public Hearing on CBD
Tetra Bio-Pharma Inc. will present key findings from its three Phase 1 and its Phase 2 cancer and non cancer investigational trials with cannabinoids.